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ABSTRACT
Ciprofloxacin is one of the most widely-used antibiotics, and has proven especially effective at controlling infections
associated with the opportunistic human pathogen, Pseudomonas aeruginosa. In this work, we show that sub-inhibitory
concentrations of ciprofloxacin induce discrete changes in the intracellular proteome. Central metabolism and cell
envelope-associated functions are particularly affected. In spite of the low magnitude of the intracellular proteomic
changes, we found that sub-lethal concentrations of ciprofloxacin had substantial effects on motility and exoprotein
secretion. Crucially, the proteomic and phenotypic modulations that we observed were absolutely dependent upon the
presence of wild-type GyrA; an isogenic strain of P. aeruginosa carrying a ciprofloxacin-insensitive form of GyrA (a T83→I
mutant) did not display ciprofloxacin-dependent changes unless complemented with wild-type gyrA in trans. These results
show that the diverse effects of sub-inhibitory ciprofloxacin on the cell are routed through its primary target in the cell,
DNA gyrase.
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INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen responsi-
ble for causing a variety of human disease states, especially
among immunocompromised individuals. Indeed, in 2017, the
World Health Organisation (WHO) named P. aeruginosa as a criti-
cal priority pathogen against which new antimicrobial interven-
tions are urgently required. One of the most effective antibiotics
used to treat P. aeruginosa infections is the second generation flu-
oroquinolone, ciprofloxacin (CIP) (Wise, Andrews and Edwards
1983). Introduced in 1987, CIP proved so effective at treating a
wide range of bacterial infections that it rapidly joined theWHO
list of medicines essential for basic healthcare. CIP has a broad
spectrum of actionwith good tissue penetration, oral absorption
and favourable phamacokinetics, making it ideal for the treat-
ment of a wide range of infections. Crucially, the presence of
the cyclopropane moiety on the N atom of the heterocycle in
CIP increases its activity (compared with first generation fluoro-
quinolones such as norfloxacin) against P. aeruginosa by a factor
of four.
In Gram-negative bacteria, the primary target of CIP is
DNA gyrase (a tetramer comprised of 2 GyrA and 2 GyrB
molecules), although topoisomerase-IV (ParC) is a secondary
target and can be inhibited by higher concentrations of the
drug. Quinolones do not bind to the gyrase enzyme alone, but
rather, to the gyrase-DNA complex (Hooper 2001). The region
of GyrA spanning residues 51–106 is known as the quinolone-
resistance determining region (QRDR), since mutations within
this sequence decrease the susceptibility of the organism to
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fluoroquinolone inhibition (Yoshida et al. 1990). Not surpris-
ingly, this stretch of sequence maps to the recognition helix
responsible for binding DNA. Among QRDR mutants, substitu-
tions at residue 83 are frequently associated with CIP resistance
in both P. aeruginosa and Escherichia coli clinical isolates
(reviewed by Hooper 1999). In many CIP-resistant gyrAmutants,
residue 83 is replaced by a bulkier, non-polar residue that is
thought to impede DNA-binding to gyrase, and hence, also
fluoroquinolone binding. Interestingly in E. coli, residue 83 is
a serine, whereas in P. aeruginosa it is the bulkier threonine;
this may correlate with the higher intrinsic resistance of P.
aeruginosa to CIP compared with E. coli (Fabrega et al. 2009).
Previous transcriptomic analyses have revealed that expo-
sure of P. aeruginosa cultures to sub-minimal inhibitory concen-
trations of CIP (sub-MICCIP) brings about large-scale changes in
gene expression, with hundreds of transcripts showing altered
abundance in CIP-treated cultures (Brazas and Hancock 2005).
This raises the question of whether these modulations are a
direct consequence of GyrA inhibition, or whether CIP also has
‘off target’ effects. To address this, in the current work, we used
quantitative 2D-difference gel electrophoresis (2D-DiGE) to com-
pare the adaptive response of wild-type P. aeruginosa and an iso-
genic T83→I gyrAmutant to sub-MICCIP. Our results suggest that
sub-MICCIP has significant impacts on central metabolism and
protein secretion, and these effects are largely dependent upon
the presence of a CIP-sensitive gyrA allele. Very few off-target
effects are apparent, even at very high concentrations of CIP.
MATERIALS AND METHODS
Bacterial strains used
The PAO1 employed in the current study was a generous gift
from Barbara Iglewski (University of Rochester, NY). HGS4 is a
derivative of that PAO1 strain.
Cloning of gyrA for complementation
A 3 kb DNA fragment including the gyrA coding re-
gion and its associated Shine-Dalgarno sequence was
PCR-amplified (LT Polymerase, primers GyrApF2 (5’-
TGAGAGCTCCCACCAGAAAAAGGAACCAG-3’) and GyrApR
(5’-AGTCAACCCGGGAGAAATTGAAGGCTCGCTTG-3’)). The frag-
ment was sequentially digested with SmaI/SacI and ligated with
pUCP20 (West et al. 1994) that had been digested with the same
enzymes. This yielded pGyrA.
Media
Unless otherwise stated, all cultures were grown in AGSY
medium (Stickland et al. 2010).
Minimum inhibitory concentration determination
Minimum inhibitory concentrations (MICs) were determined us-
ing E-Test strips laid onto a lawn of the relevant strain grown on
the surface of AGSY-agar plates.
Whole cell 2D-DiGE Proteomic Analysis
2D-DiGE Biological Variance Analysis (BVA; GE Healthcare) was
used to analyse the proteomic changes accompanying treat-
ment of wild-type P. aeruginosa and the isogenic T83→I gyrA
mutant to sub-MICCIP. Four independent biological replicates of
wild-type PAO1 (each treated with 0, 0.05, 0.075 μg/ml CIP) and
HGS4 (0, 0.075, 0.25 μg/ml CIP) cultures were analysed. When
present, sub-MICCIP was added at the start of each growth curve.
The cultures were grown in AGSY medium with good aeration,
as previously described (Stickland et al. 2010) and harvested for
proteomic analysis when they reached early stationary phase
(OD600 = 6, ca. 5–6 hrs after inoculation). The 2D-DiGE, spot iden-
tification and statistical analyses were carried out as previously
described (Stickland et al. 2010).
Secretome protein extraction
Protein from the secretome of PAO1 (pUCP20), HGS4 (pUCP20)
and HGS4 (pGyrA) cultures grown with or without 0.075 μg/ml
CIP was analysed. Extracellular material was collected at
OD600 = 6 from cultures grown in AGSY supplemented with
50 μg/ml carbenicillin (to maintain the introduced pUCP20 or
pUCP20-derived plasmids). Secreted proteins were precipitated
from filter-sterilised culture supernatant by addition of 12.5%
(w/v, final concentration) trichloroacetic acid (TCA), essentially
as described previously (Swatton et al. 2016). The mixture was
left on ice overnight and precipitated proteins were collected
by centrifugation (12,000 × g, 4◦C). The pellet was washed three
times in 80% acetone, air-dried, and then resuspended in 50mM
Tris-HCl (pH 6.8) containing 10% glycerol and 2% SDS. The pH
was adjusted to ∼ pH 7 and the protein concentration was de-
termined (BioRad detergent-compatible quantification kit). Pro-
teins were resolved by SDS-PAGE (10–20% gradient gels).
Swarming
For swarming motility assays, 5 μl of an overnight culture di-
luted to an OD of 0.1 was carefully pipetted onto the surface of
0.7% (w/v) Eiken agar prepared in AGSY medium and incubated
overnight. The plates were incubated at 30◦C so that motility
zones were not too large to measure. Swarming motility was
qualitatively assessed by how far the cells had travelled from
the point of inoculation and for tendril formation.
RESULTS
Isolation of a spontaneous ciprofloxacin-resistant gyrA
mutant
Wild-type PAO1 (MICCIP = 0.25 μg/ml in AGSY medium) was in-
oculated into AGSY medium containing 1 μg/ml CIP and incu-
bated with good aeration at 37◦C. After 24 hours, the culture
had become cloudy, indicating the emergence of spontaneous
CIP-resistantmutant(s). Samples from the 24 hours culture were
serially-diluted and spread onto agar plates containing 1 μg/ml
CIP to yield single colonies. A range of colonymorphotypes were
observed. Targeted PCR/sequence analysis revealed that some
of these colonies contained nfxB mutations (which lead to up-
regulation of the normally cryptic mexCD-oprJ CIP efflux pump
(Poole et al. 1996; Jeannot et al. 2008)), whereas others were wild-
type for nfxB. These results indicate that even within a single
overnight culture, CIP-resistance can arise due to different mu-
tations. A single CIP-resistant colony that did not contain an nfxB
mutation was picked for further analysis. Targeted PCR amplifi-
cation and sequencing of the QRDR of gyrA revealed that the am-
plicon contained a C→T transition converting the Thr83 codon
(ACC) in the gyrA ORF to an Ile codon (ATC). The T83→I alter-
ation is a well-established cause of CIP-resistance (Hooper 1999;
Hooper 2001). This gyrA mutant was named HGS4. The QRDR of
Downloaded from https://academic.oup.com/femsle/article-abstract/365/13/fny134/5017444
by guest
on 08 August 2018
Jedrey et al. 3
Figure 1. (A) E-Test strips showing the MICCIP of HGS4 (the gyrA T83→I mutant)
containing either pUCP20 (upper panel) or pGyrA (lower panel). (B) Growth of
PAO1 in the presence of increasing concentrations of CIP. Open Symbols/solid
line; wild-type, filled symbols/dashed line; HGS4. (©); untreated PAO1, ()
0.05μg/mL CIP (PAO1), (); 0.075μg/mL CIP (PAO1), (•); untreatedHGS4, (); 0.075
μg/mL CIP (HGS4), (); 0.25 μg/mL CIP (HGS4).
the parC locus was also amplified and sequenced to confirm that
no parCmutationswere present inHGS4. To further demonstrate
that the increased CIP-resistance of HGS4 was solely due to the
gyrA mutation, the gyrA ORF and its associated Shine-Dalgarno
sequence was PCR-amplified from wild-type genomic DNA and
cloned into pUCP20, generating pGyrA. The MICCIP of pGyrA-
complemented HGS4 was restored to near wild-type levels (ca.
0.5 μg/mL), whereas the MICCIP of HGS4 containing pUCP20
remained high (MICCIP = 4–6 μg/ml (Fig. 1A).
Proteomic adaptations of P. aeruginosa to ciprofloxacin
CIP concentrations of ≤ 0.075 μg/ml (corresponding to
0.3 × MICwild-type) did not affect the growth of PAO1 in AGSY,
although concentrations greater than this led to a reduction in
growth rate and stationary phase optical density. In contrast,
the gyrA mutant (HGS4) tolerated concentrations of 0.25 μg/ml
CIP (1 × the wild-type MICCIP) without any apparent effect(s)
on growth (Fig. 1B). For proteomic analysis, we therefore chal-
lenged wild-type PAO1 cultures with 0.05 μg/ml CIP and 0.075
μg/ml CIP (0.2 × MIC and 0.3 × MIC, respectively), whereas
the HGS4 cultures were challenged with 0.075 μg/ml CIP and
0.25 μg/ml CIP. These concentrations were selected for study (i)
to allow comparison of the proteomic changes brought about
at the highest non-growth rate impairing concentration of
CIP in the wild-type (0.075 μg/ml) with the target site mutant
(HGS4), and, (ii) to examine whether a lethal concentration (for
the wild-type strain) of CIP elicits any proteomic changes in
the target site mutant (0.25 μg/ml CIP is equal to the MIC of the
wild-type strain). Untreated cultures served as controls. Whole
cell lysates were analyzed by 2D-difference gel electrophoresis
(2D-DiGE) using a BVA protocol, allowing smaller fold-changes
to be reliably determined (Stickland et al. 2010). This work
was carried out as part of a larger BVA, which also included
comparison of the wild-type with an nfxB mutant. Mutations in
nfxB confer resistance to CIP by up-regulating expression of the
MexCD-OprJ efflux pump (Shiba et al. 1995; Poole et al. 1996). Our
findings assessing the impact of nfxBmutation on the proteome
have been previously published (Stickland et al. 2010) and the
master gel for the BVA was presented in that study. Until now,
the outcome of the second half of that BVA study (examining
the impact of CIP on the wild-type proteome) has not been
reported.
The average ratio of standardized protein spot abundance
was calculated for each of the spots in the filtered dataset. To
our surprise, even the highest concentration of CIP tested had
little effect on the global proteome; only 24 protein spots (out
of a total of 853 spots) were significantly (P ≤ 0.01) modulated
in the CIP-treated wild-type samples compared with the un-
treated controls (Fig. 2, upper panel). Interestingly, not all of the
proteins that were modulated at the lower concentration of CIP
(0.05 μg/ml) were also modulated at the higher concentration
(0.075 μg/ml) of CIP (although there was some overlap). This
may indicate that the cell implements a ‘graded’ response to the
antibiotic, possibly reflecting the impact of differential gyrase
inhibition on gene expression profiles (DNA gyrase-dependent
supercoiling is known to influence transcription (reviewed by
Dorman and Dorman 2016)) or differential stimulation of reac-
tive oxygen species production (see Discussion). The proteome
of untreated HGS4 was essentially indistinguishable from that
of the untreated wild-type (data not shown). This indicates that
the T83→I substitution in HGS4 GyrA does not in itself lead to
obvious cellular perturbations. Also, fewer and smaller changes
were elicited by addition of CIP to HGS4 cultures (Fig. 2, lower
panel). None of the spots modulated by CIP in HGS4 overlapped
with the CIP-modulated spots in the wild-type. These data
suggest that in the wild-type, most of the observed changes are
dependent upon the interaction of CIP with GyrA.
Multivariate analysis of the proteomic data
Our finding, that only small numbers of protein spots were sig-
nificantly modulated by sub-MICCIP exposure, contrasts strongly
with earlier microarray experiments which reported that hun-
dreds of transcripts are modulated by sub-MICCIP (Brazas and
Hancock 2005). One possible explanation for this disparity is
that many of the proteomic changes elicited by CIP treatment
are subtle and escape detection based on univariate statistical
analyses, which only assess pairwise comparisons. We there-
fore re-analysed the proteomic dataset using an unsupervised
multivariate approach, principal components analysis (PCA). A
scores plot of the first two principal components in the model
(Fig. 3A) shows that the CIP-treated wild-type samples show a
trend towards segregating away from the untreated samples,
with the higher CIP concentration driving greater separation. To
further tease out the drivers underpinning these separations,
a more sensitive, supervised approach (partial least squares-
discriminant analysis, PLS-DA) was employed. The first compo-
nent accounted for themajority (83%) of the differences between
the sample types (data not shown). To establish how many pro-
tein spots contributed towards this separation, we iteratively
removed spots from the PLS-DA model until the robustness
(Q2 value) of the model collapsed (Fig. 3B) (Karp, Griffin and
Lilley 2005). This happened after ∼200 ± 25 protein spots were
removed, indicating that around 23% (200/853 spots) of the ob-
served proteome was modulated by sub-MICCIP treatment. Our
data are therefore broadly consistent with earlier microarray-
based approaches indicating that CIP-induced alterations
involve hundreds of gene products. Many of these modulations
were subtle and involved low-fold changes, consistent with
maintenance of a relatively constant intracellular proteomic
steady state.
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Figure 2. Numbers of protein spots modulated (P ≤ 0.01) in the cell-associated proteome of (A) the wild-type or (B) HGS4 following exposure to the indicated concen-
tration of CIP (all modulations relative to the untreated wild-type or HGS4 proteome, respectively). The tables show whether the spots were up- or downregulated. For
example, of the 12 spots that were modulated by 0.05 μg/mL CIP in the wild-type, 3 showed decreased abundance in the treated samples (cf. the untreated samples)
and 9 showed increased abundance in the treated samples.
Figure 3. Sub-MICCIP causes global changes in the proteome. (A) PCA scores plot showing samples of the wild-type treated with no CIP (open squares), 0.05 μg/ml
CIP (gray triangles), and 0.075 μg/ml CIP (black triangles). Each data point represents the eigenvalues (PC1 and PC2, respectively) of the corresponding normalized
eigenvectors. (B) A PLS-DA model was constructed in which the first component accounted for 83% of the proteomic differences between untreated and treated (0.075
μg/ml CIP) samples. The model had good predictive power (Q2 = 58%). In an iterative process involving removal of the top 50 spots, followed by recalculation of the
model, we found that themodel collapsed (i.e. lost predictive power) after removal of 200 ± 25 spots. This indicates that sub-MICCIP treatment of wild-type P. aeruginosa
alters the abundance of two hundred protein spots.
Identities of the modulated spots
A selection of the CIP-modulated spots identified in both the
multivariate and t-test analyses were excised from the gels
and tryptically digested to yield peptide fragments. These
peptides were then identified by LC-MS/MS analysis and
MASCOT searching. Spots which yielded identities for two
or more proteins (i.e. ‘mixture hits’ arising from overlapping
spots) were excluded from further analysis. The identified
proteins in the CIP-modulated spots from the wild-type and
HGS4 samples are shown in Table 1 and Table S1, respec-
tively. There was no overlap between the identified proteins
in the wild-type and HGS4 samples. The modulated spots
were classified into functional groups according to their
PseudoCAP ontology (www.pseudomonas.com/). Notably, CIP
treatment resulted in the modulation of several enzymes
catalyzing reactions that are either part of the TCA cycle or
that feed in/out of the TCA cycle. These include pyruvate
kinase (PykA), the superoxide-insensitive isozyme of fumarate
hydratase (FumC1), two differentially modulated isozymes of
isocitrate dehydrogenase (PA2623 (icd, down-regulated) and
PA2624 (idh, up-regulated)) and malic enzyme. Consistent with
the up-regulation of FumC1 (indicating oxidative stress), we
also observed that the house-keeping catalase (KatA) was
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TABLE 1. Identity of selected spots whose abundance was modulated in wild-type PAO1 cultures by sub-MICCIP.
Fold change Identified in:
PA
number Gene Modulation
0.05
μg/ml CIP
0.075μg/ml
CIP t-test PLS-DA Protein
Amino acid biosynthesis and metabolism, translation, post translational modification and degradation
5013 ilvE ↑ 1.67 ©  Branched-chain amino acid
transferase
2709 cysK ↓  Cysteine synthase A
0400 (metB) ↑  Probable cystathionine gamma-lyase
1750 ↓ –1.21 © Phospho-2-dehydro-3-
deoxyheptonate
aldolase
5038 aroB ↓ –1.37 © 3-dehydroquinate synthase
0956 proS ↑ 1.67 © Prolyl-tRNA synthetase
Central intermediary metabolism, energy metabolism and carbon compound metabolism
2623 icd ↓ –1.3 © Isocitrate dehydrogenase
2624 idh ↑ 1.78 ©  Isocitrate dehydrogenase
4329 pykA ↑ 1.47 © Pyruvate kinase II
4470 fumC1 ↑ ∗ Fumarate hydratase (fumarase)
5046 ↓ –1.33 © Malic enzyme
5554 atpD ↑  ATP synthase beta chain
Putative enzymes
4079 ↓ –1.78 ©  Probable dehydrogenase
Adaption and protection, chaperones and heat shock
4236 katA ↑ 1.48 © Catalase
4385 groEL ↑ ∗ GroEL chaperonin
Cell wall/LPS/capsule—includes other categories: cell division, motility and attachment and secreted factors
4417 murE ↑ 1.32 1.78 ©  UDP-MurNac-tripeptide synthetase
4481 mreB ↓  Rod shape-determining protein MreB
1094 fliD ↓  Flagellar capping protein FliD
0766 mucD ↓  Serine protease MucD precursor
Transport of small molecules
4595 (yjjK) ↓ –1.41 © Probable ATP-binding component of
ABC transporter
1810 nppA2 ↑  Peptidyl nucleoside antibiotic
transporter (periplasmic binding
protein)
Nucleotide biosynthesis and metabolism
1013 purC ↓ –1.43 © Phosphoribosylaminoimidazole-
succinocarboxamide synthase
A protein modulation was designated as significant if identified by t-test (P ≤ 0.01). T-tests were carried out comparing untreated wild-type samples with wild-type
samples that had been treated with the indicated concentration of CIP. The magnitude and direction of modulation is shown as fold-change (for proteins identified
by t-test) and by the arrows. A protein identification was considered significant if the MASCOT score was > 106 (the equivalent of two different significant peptide ion
matches). ∗ Indicates that a protein was identified in more than one spot.
up-regulated. Other notable modulated proteins included the
chaperonin, GroEL (multiple spots up-regulated), the flagellar
capping protein, FliD, proteins involved in cell envelope main-
tenance such as MurE (UDP-MurNac-tripeptide synthetase;
up-regulated) and MreB (a DnaK-like molecular chaperone
involved in determining cell shape; down-regulated) and a
DegP/HtrA-like serine protease (MucD) involved in the con-
trol of alginate production and response of envelope stress
(down-regulated).
Of the identified proteins modulated in HGS4, most were
down-regulated, and most of these were affected only at
the higher concentration of CIP tested (0.25 μg/ml), perhaps
indicative of off-target or secondary target effects of CIP. Most
notably, GyrB was down-regulated, as was the AAA + ATPase
family chaperone, ClpB.
Phenotypic consequences of CIP-challenge
To investigate the possible consequences of the proteomic mod-
ulations, we examined a selection of phenotypes that might be
affected by these. Motility plays a key role in infection, and our
proteomic analysis showed that the flagellar capping protein,
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Figure 4. Ciprofloxacin depresses tendril formation during surface swarming by
inhibiting GyrA. Aliquots of culture containing the indicated strains were spot-
ted onto 0.7% (w/v) Eiken agar plates and left at 30◦C to allow swarm develop-
ment. (i) WT (pUCP20), (ii) HGS4 (pUCP20) and (iii) HGS4 (pGyrA). Note that CIP
depresses tendril formation in the wild-type but not in the gyrA T83→I mutant,
HGS4. However, tendril formation is depressed in HGS4 following expression of
wild-type gyrA in trans.
FliD, was down-regulated in the presence of CIP. Consistent with
this, we noted that the surface swarming ability of wild-type
P. aeruginosa was impaired in the presence of 0.075 μg/ml CIP
(Fig. 4). No impairment of motility was seen in the CIP-treated
HGS4 mutant. However, when HGS4 was complemented with
pGyrA, surface swarming once again became sensitive to the
presence of CIP. We conclude that the effect of CIP on motility
is dependent on the presence of a susceptible gyrA allele in the
wild-type.
The altered motility elicited by CIP, as well as the identifi-
cation of several CIP-modulated proteins associated with cell
envelope physiology made us wonder whether protein secre-
tion might be affected by the drug. Indeed, earlier workers have
shown that CIP treatment of P. aeruginosa biofilms alters the
spectrum of proteases secreted (Oldak and Trafny 2005). There-
fore, we used 1D SDS-PAGE to analyse the secretome of wild-
type PAO1 (pUCP20), HGS4 (pUCP20) and HGS4 (pGyrA). Sub-MIC
CIP caused clear alterations in the profile of proteins secreted by
cultures of wild-type PAO1, but no obvious major alterations in
the protein profile secreted by HGS4 (Fig. 5, upper panel). How-
ever, when HGS4 was complemented with pGyrA, the secre-
tome once again became sensitive to CIP addition. These data
suggest that sub-MICCIP treatment impacts upon protein secre-
tion by P. aeruginosa through its effects on GyrA. To confirm that
the observed secretome alterations were not due to increased
CIP-dependent cell lysis, we used Western blotting to assess
β-lactamase levels in the secretome samples. β-lactamase is
constitutively expressed from the pUCP20 plasmids in each
strain and is a periplasmic enzyme. Therefore, release of
β-lactamase is a good indicator of cell envelope integrity. There
was no evidence of enhanced cell lysis in the CIP-treated sam-
ples (Fig. 5, lower panel).
DISCUSSION
In this study, we show that the adaptive response to sub-MICCIP
involves a small number of moderate (<2-fold) changes in in-
tracellular protein abundance, and a much larger number of
lower-fold modulations. These subtle modulations are consis-
tent with maintenance of a relatively constant overall intracel-
lular steady state proteome. Larger CIP-induced proteomicmod-
ulations were seen in the exoproteome, which is presumably
subject to less stringent control of its composition. However, we
also show that in spite of the low magnitude of the intracellu-
Figure 5. Sub-MICCIP causes changes in the P. aeruginosa secretome. The figure
shows a 1D SDS-PAGE gel stained with Coomassie Brilliant Blue (upper panel) of
secretome samples from cultures of the indicated strains grown ± 0.075 μg/ml
CIP. Below this (lower panel) is a Western blot of the same samples probed with
an antibody (from 5prime3prime) reactive against the β-lactamase encoded on
the pUCP20 plasmid. Asterisks indicate laneswhere the secretome is clearly very
different compared with the untreated wild-type control.
lar proteomicmodulations, some of these have clear phenotypic
consequences. We further show that these sub-MICCIP-induced
phenotypic and proteomic changes are absolutely dependent
upon the drug interacting with wild-type (CIP-sensitive) GyrA.
Indeed, even at a concentration of CIP that completely prevents
the growth of wild-type cultures (i.e. 0.25 μg/ml, equal to the
MICCIP of PAO1), the gyrAT83I mutant showed very few proteomic
changes.
In a previous study, Brazas et al used microarray analysis to
investigate the effects of sub-MICCIP on the global gene expres-
sion profile of P. aeruginosa (Brazas and Hancock 2005). Those
workers found that the transcripts from 941 genes were affected
in the presence of 0.3×MICCIP. In contrast, we observed that only
around 200 protein spots were affected by 0.3×MICCIP. However,
this may simply reflect differences in the relative sampling effi-
ciency (i.e. gene products detectable) of proteomics compared
with transcriptomics. Moreover, 60% of the gene products re-
ported in the current study were not reported as being modu-
lated by Brazas et al. and of the gene products that were com-
mon to both studies, only four (GroEL, Icd, IlvE and PA4595) were
modulated in the same direction. It seems likely that the main
driver for the disparity between the two studies lies in biological
differences, probably related to the different growth conditions
employed (Brazas et al employed oligopeptide-based LB for their
study, while we used alanine-glycerol-salts medium).
Why should inhibition of DNA gyrase lead to pleiotropic
changes in the cell? Davies and colleagues have shown that the
cellular response to many antibiotics exhibits the property of
hormesis, suggesting that these compounds may have evolved
as intercellular signals (Davies, Spiegelman and Yim 2006). A
variation on this scenario is that low concentrations of antibi-
otic may induce protective measures that ‘prime’ the cell ready
to respond higher concentrations of the same compound. While
this may indeed be the case, we note that CIP is an entirely
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synthetic antibiotic, so there is no reason to believe that the
cell will have evolved mechanisms to respond specifically to
its presence. However, just as the ribosome can titrate trans-
lational inhibitors, we suspect that DNA gyrase may monitor
the general ‘state of health’ of the genome and allow the cell
to adapt accordingly. Two possible generic gyrase-dependent
adaptatory mechanisms present themselves. First, the observed
proteomic modulations may arise as a consequence of altered
gene expression brought about directly by GyrA inhibition.
Indeed, DNA gyrase-dependent supercoiling is known to affect
the expression of many genes (Dorman and Dorman 2016). In
this scenario, adaptations which protect against the effects of
GyrA inhibition would be hardwired into the global gyrase reg-
ulon. The second mechanism is indirect and involves adaptive
measures that protect against the bactericidal effect(s) of the
antibiotic. Kohanski et al. (2007) have proposed that all bacterici-
dal antibiotics (including CIP) exhibit a common mechanism of
killing. In this model, inhibition of the target molecule activity
leads, via transient stimulation of superoxide production, to
a runaway Fenton reaction and subsequent accumulation of
lethal hydroxyl radicals. In this case, the proteomic changes in-
duced by exposure to low concentrations of the antibiotic would
be expected to comprise part of the cell’s adaptive response to
the imposed (antibiotic-dependent) oxidative stress. While we
cannot distinguish between these two possible modes of action,
it is clear from Table 1 that enzymes involved in the response
to oxidative stress (KatA, FumC1) are indeed up-regulated by
exposure to sub-MICCIP.
Another set of potentially related gene products that were
modulated by sub-MICCIP are involved in metabolism. Malic
enzyme (PA5046), which catalyses the oxidative decarboxyla-
tion of malate to yield pyruvate, was down-regulated, whereas
pyruvate kinase (PykA) was up-regulated. This suggests that a
net effect of CIP exposure is to decrease the flow of metabolites
out of the TCA cycle (e.g. for gluconeogenesis) and increase the
flux of carbon going into the cycle. In addition, the isocitrate
dehydrogenase encoded by icd was down-regulated whereas
the NADP-dependent isocitrate dehydrogenase isozyme en-
coded by idh was up-regulated. Little is known about these
two isozymes in P. aeruginosa, although it seems likely that
they are differentially regulated. Crucially, the products of
the isocitrate dehydrogenase reaction are α-ketoglutarate and
NADPH, both of which play an important role in the response to
oxidative stress (Mailloux et al. 2007; Spaans et al. 2015). Taken
together, it seems likely that exposure to sub-MICCIP leads to an
accumulation of reactive oxygen species (as per the Kohanski
model), and that in response to this, the cell increases flux
around the TCA cycle to generate α-ketoglutarate and NADPH.
Consistent with this, we further note that the cystathionine
γ -lyase, MetB, was also up-regulated upon exposure to CIP.
Cystathionine γ -lyase breaks down cystathionine to yield
α-ketoglutarate.
Interestingly, one of the gene products (PA4595) identified
in both this and a previous transcriptomic study (Brazas and
Hancock 2005) as being down-regulated in the presence of sub-
MICCIP is a predicted ATP-binding component of an ABC trans-
porter. The PA4595 gene is located immediately adjacent to a cell
envelope stress-inducible nfxB-like repressor, esrC. EsrC and nfxB
flank themexCD-oprJmultidrug efflux pump, well-known for be-
ing a major determinant of CIP resistance (Stickland et al. 2010),
and both regulators are known to affect expression of the pump
under different conditions (Purssell et al. 2015). The functional
relationship, if any, between PA4595 and EsrC/MexCD-OprJ/NfxB
is not clear, and the location of PA4595 adjacent to this known
CIP resistance determinant may be entirely coincidental. How-
ever, we previously showed that the protein encoded by PA4595
is up-regulated in an nfxBmutant (Stickland et al. 2010), suggest-
ing a possible functional linkage.
In summary, we have shown that exposure to sub-MICCIP
leads to re-modelling of the intracellular proteome. This re-
modeling has phenotypic consequences, and is dependent on
the binding of CIP to a sensitive GyrA protein. Many of the pro-
teomic changes that are elicited by sub-MICCIP appear to be
linked with the cellular response to oxidative stress, although
we cannot exclude the possibility that some of these modu-
lations reflect an altered DNA supercoiling state in the cell as
the DNA gyrase becomes progressively more inhibited by higher
concentrations of CIP.
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